MBD4 Knock Down Cell Line (MTA Required prior to shipment)
#
-
Catalog number5506-001-01
-
Price:
-
Size1 vial
-
-
Keep atLN
-
First batchSaturday, September 30, 2006
-
Assay performanceCometAssay, DNA Damage, PCR and Molecular Biology, Oxidative Damage, PARP research.
-
More adviceTrevigen offers Angiogenesis/Cell Differentiation, antibodies, apoptosis, signal_transduction, Basement Membrane Proteins.
-
DescriptionFor cells, cell lines and tissues in culture till half confluency.
-
Gene target
-
Gene symbolMBD4
-
Short nameMBD4 Knock Down Line (MTA Required prior shipment)
-
Alternative namemethyl-CpG binding domain protein 4 Knock Down cellular Line (MTA Required prior to shipment)
-
Alternative to gene targetmethyl-CpG binding domain protein 4, MED1, MBD4 and IDBG-55837 and ENSG00000129071 and 8930, pyrimidine-specific mismatch base pair DNA N-glycosylase activity, nuclei, Mbd4 and IDBG-179645 and ENSMUSG00000030322 and 17193, BT.49400 and IDBG-646370 and ENSBTAG00000021645 and 511463
-
Tissuecell
-
Gene info
-
Identity
-
Gene
-
Long gene namemethyl-CpG binding domain 4, DNA glycosylase
-
Synonyms gene name
- methyl-CpG binding domain protein 4
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1999-01-11
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- DNA glycosylases
- Methyl-CpG binding domain containing
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES.
-
Tree numbers
- E05.393.335.500
-
Qualifiersethics, mortality, psychology, trends, veterinary, history, classification, economics, instrumentation, methods, nursing, standards, adverse effects, statistics & numerical data